We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$184B
AUM Growth
+$184B
Cap. Flow
+$1.06B
Cap. Flow %
0.58%
Top 10 Hldgs %
15.06%
Holding
4,187
New
96
Increased
2,386
Reduced
984
Closed
127

Top Buys

Rank Stock Value
1
SPGI icon
S&P Global
SPGI
+$216M
2
CHTR icon
Charter Communications
CHTR
+$192M
3
SLB icon
SLB Ltd
SLB
+$79.3M
4
IBM icon
IBM
IBM
+$70.2M
5
NWL icon
Newell Brands
NWL
+$67.5M

Top Sells

Rank Stock Value
1
GE icon
GE Aerospace
GE
+$72.2M
2
MSFT icon
Microsoft
MSFT
+$66.1M
3
UAA icon
Under Armour
UAA
+$63.2M
4
XOM icon
ExxonMobil
XOM
+$51.6M
5
WCN
Waste Connections
WCN
+$51.5M

Sector Composition

Rank Sector Weight
1 Healthcare 14.47%
2 Technology 14.08%
3 Financials 13.83%
4 Industrials 10.22%
5 Consumer Discretionary 9.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNT icon
3876
Ceragon Networks
CRNT
$203M
$42K ﹤0.01%
26,165
MATN
3877
DELISTED
Mateon Therapeutics, Inc.
MATN
$42K ﹤0.01%
+60,393
New +$42.8K
NSPH
3878
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$42K ﹤0.01%
24,637
WWR icon
3879
Westwater Resources
WWR
$54.1M
$41K ﹤0.01%
513
XPLR
3880
DELISTED
Xplore Technologies Corp.
XPLR
$40K ﹤0.01%
16,945
FAC
3881
DELISTED
First Acceptance Corp.
FAC
$40K ﹤0.01%
28,734
GYRE icon
3882
Gyre Therapeutics
GYRE
$695M
$39K ﹤0.01%
228
SONN
3883
DELISTED
Sonnet BioTherapeutics
SONN
0
VKTX icon
3884
Viking Therapeutics
VKTX
$3.91B
$39K ﹤0.01%
+31,264
New +$41.2K
WPRT
3885
Westport Fuel Systems
WPRT
$35.5M
$39K ﹤0.01%
2,352
-446
-16% -$9.6K
XPL icon
3886
Solitario Resources
XPL
$68.9M
$39K ﹤0.01%
75,942
IMNP
3887
DELISTED
Immune Pharmaceuticals Inc.
IMNP
$39K ﹤0.01%
4,996
JRJR
3888
DELISTED
JRjr33, Inc.
JRJR
$39K ﹤0.01%
44,389
CNVS icon
3889
Cineverse
CNVS
$62.8M
$38K ﹤0.01%
1,604
QCLS
3890
Q/C Technologies Inc
QCLS
$23.2M
0
VISL
3891
DELISTED
Vislink Technologies, Inc. Common Stock
VISL
$38K ﹤0.01%
+3
New +$51.1K
ACUR
3892
DELISTED
Acura Pharmaceuticals
ACUR
$38K ﹤0.01%
21,024
LPTH icon
3893
Lightpath Technologies
LPTH
$753M
$37K ﹤0.01%
21,491
WHLR
3894
Wheeler Real Estate Investment Trust
WHLR
$481K
0
EPRS
3895
DELISTED
EPIRUS BIOPHARMACEUTICALS INC COM
EPRS
$37K ﹤0.01%
82,821
ALBO
3896
DELISTED
Albireo Pharma Inc
ALBO
$36K ﹤0.01%
3,902
EVFM
3897
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$35K ﹤0.01%
399
ERN
3898
DELISTED
Erin Energy Corp
ERN
$34K ﹤0.01%
14,124
+2,625
+23% +$5.5K
DSKX
3899
DELISTED
DS HEALTHCARE GROUP, INC. NEW COMMON STOCK
DSKX
$34K ﹤0.01%
52,113
IFO
3900
DELISTED
INFOSONICS CORPORATION
IFO
$34K ﹤0.01%
41,938

Similar funds

Geode Capital Management's Q2 2016 Portfolio in Review

As of Q2 2016, Geode Capital Management held 4,187 positions worth $184B, up 97,477% from $188M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Geode Capital Management's Q2 2016 filing shows 96 new, 2,386 increased, 984 reduced and 127 closed positions. Its largest new stake was S&P Global: 2,009,728 shares worth $215M. The largest sale was GE Aerospace, an estimated $72.2M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 14% a quarter earlier, followed by Technology and Financials.

  • Geode Capital Management's largest Q2 2016 buy was S&P Global: 2,009,728 shares worth $215M.
  • Geode Capital Management added most to Charter Communications in Q2 2016, an estimated $192M increase.
  • Geode Capital Management's biggest Q2 2016 reduction was GE Aerospace, cutting an estimated $72.2M.
  • Geode Capital Management fully exited Affymetrix Inc in Q2 2016, selling an estimated $7.53M.
  • Geode Capital Management's ten largest holdings make up 15% of its $184B portfolio in Q2 2016.
  • Geode Capital Management opened 96 new positions and closed 127 in Q2 2016.
  • Geode Capital Management's portfolio value rose 97,477% quarter-over-quarter to $184B.

Based on Geode Capital Management's 13F filing for Q2 2016, filed 12 Aug 2016.